Cannabis During Pregnancy and Risk of Adverse Birth Outcomes

Cannabis During Pregnancy and Risk of Adverse Birth Outcomes

Cannabis during pregnancy increases the risk of premature birth, low birth weight, and neonatal intensive care in infants, according to a new study from researchers at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto.

The study, which was published in the journal Addiction, also discovered that cannabis-exposed newborns are not at a higher risk of birth abnormalities or mortality within one year, including sudden unexpected infant death.

“The global increase in cannabis use among women of reproductive age also extends to pregnant women,” says Maryam Sorkhou, a PhD student and principal author on the study at the University of Toronto’s Temerty Faculty of Medicine’s Institute of Medical Science. “We know that THC, the main psychoactive constituent in cannabis, can cross the placenta from mother to fetus and bind to receptors in the fetal brain.”

Tony George, a clinician-scientist at CAMH and a professor in the Temerty Faculty of Medicine’s department of psychiatry and Institute of Medical Science, collaborated with Sorkhou on the project.

This study combined the findings of 57 previous investigations from throughout the world.

These investigations took place between 1984 and 2023 and involved the health outcomes of almost 12 million newborns, including over 102,000 infants who were exposed to cannabis before birth.

For example, 20 of the included studies assessed the relationship between intrauterine cannabis exposure and the risk of premature delivery.

The combined data suggest that moms who used cannabis during pregnancy were more than 1.5 times more likely to have a premature delivery than mothers who did not use cannabis during pregnancy.

Another 18 papers included in the review assessed the risk of low birth weight.

The combined findings suggest that mothers who used cannabis during pregnancy were more than twice as likely to have a low-birth-weight infant than mothers who did not use cannabis during pregnancy.

Ten of the included trials additionally assessed the likelihood of requiring NICU hospitalization.

The pooled data suggest that neonates with intrauterine cannabis exposure were more than twice as likely as non-exposed newborns to require NICU hospitalization.

“Our study adds to that knowledge by showing that prenatal exposure to cannabis heightens the risk of several adverse birth outcomes,” says Sorkhou.

For more information: Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta-analysis, Journal Addiction

https://onlinelibrary.wiley.com/doi/10.1111/add.16370

Driven by a deep passion for healthcare, Haritha is a dedicated medical content writer with a knack for transforming complex concepts into accessible, engaging narratives. With extensive writing experience, she brings a unique blend of expertise and creativity to every piece, empowering readers with valuable insights into the world of medicine.

more recommended stories